Forte Bioscience Pop; Astrazeneca Reports; Paramount-Warner Latest

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- Forte Bioscience (FBRX) is soaring as Argenx SE agreed to buy Forte Biosciences Inc. for about $2.2 billion in cash to expand its portfolio of immunology medicines.

- Astrazeneca (AZN) shares after it reported higher-than-expected profit, buoyed by blockbuster cancer medicines, with earnings per share rising 21% to $2.63 last quarter.

- Paramount Skydance (PSKY) shares are reacting to news that it paused its blockbuster deal for Warner Bros.

See omnystudio.com/listener for privacy information.